TGTX icon

TG Therapeutics
TGTX

Overview Fund Activity

233 hedge funds and large institutions have $1.57B invested in TG Therapeutics in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 78 increasing their positions, 70 reducing their positions, and 39 closing their positions.

Holders
233
Holders Change
-2
Holders Change %
-0.85%
% of All Funds
3.42%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
39
Increased
78
Reduced
70
Closed
39
Calls
$85.5M
Puts
$63.8M
Net Calls
+$21.7M
Net Calls Change
+$20.4M

Top Buyers

1
DGM
1
Darwin Global Management
Jersey
$69.1M
2
Pictet Asset Management
2
Pictet Asset Management
Switzerland
$57.8M
3
WP
3
Woodline Partners
California
$30.2M
4
Morgan Stanley
4
Morgan Stanley
New York
$50.9M
5
Marshall Wace
5
Marshall Wace
United Kingdom
$17.4M

Top Sellers

1
SCM
1
Soleus Capital Management
Connecticut
$11.1M
2
Two Sigma Investments
2
Two Sigma Investments
New York
$2.64M
3
State Street
3
State Street
Massachusetts
$141M
4
PBA
4
Paradigm Biocapital Advisors
New York
$37.1M
5
SSA
5
Schonfeld Strategic Advisors
New York
$5.76M
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$233M 13,670,944 +199,770 +1%
BlackRock
2
BlackRock
New York
$184M 10,768,163 +781,216 +8%
State Street
3
State Street
Massachusetts
$141M 8,253,573 -1,564,049 -16%
DGM
4
Darwin Global Management
Jersey
$69.1M 4,046,598 +4,046,598 New
Pictet Asset Management
5
Pictet Asset Management
Switzerland
$57.8M 3,385,245 +2,564,842 +313%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$53.6M 3,139,764 +43,290 +1%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$52.9M 3,096,646 +162,820 +6%
Morgan Stanley
8
Morgan Stanley
New York
$50.9M 2,978,966 +1,102,286 +59%
Millennium Management
9
Millennium Management
New York
$50M 2,928,788 +912,357 +45%
OM
10
Opaleye Management
Massachusetts
$37.8M 2,215,000 +325,000 +17%
PBA
11
Paradigm Biocapital Advisors
New York
$37.1M 2,171,419 -1,447,596 -40%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$33.3M 1,948,657 +570,896 +41%
WP
13
Woodline Partners
California
$30.2M 1,768,434 +1,616,295 +1,062%
6CM
14
683 Capital Management
New York
$28.6M 1,675,000 +325,000 +24%
Goldman Sachs
15
Goldman Sachs
New York
$28.2M 1,649,837 -41,113 -2%
Fidelity Investments
16
Fidelity Investments
Massachusetts
$27M 1,579,511 +650,673 +70%
Northern Trust
17
Northern Trust
Illinois
$23.1M 1,350,935 -7,063 -0.5%
Nuveen Asset Management
18
Nuveen Asset Management
Illinois
$23.1M 1,350,721 +968,611 +253%
Charles Schwab
19
Charles Schwab
California
$19.3M 1,131,896 +19,214 +2%
Norges Bank
20
Norges Bank
Norway
$18.4M 1,075,037 +152,925 +17%
Marshall Wace
21
Marshall Wace
United Kingdom
$17.4M 1,020,102 +1,020,102 New
Group One Trading
22
Group One Trading
Illinois
$17M 996,842 +339,803 +52%
Renaissance Technologies
23
Renaissance Technologies
New York
$14.3M 839,200 -537,262 -39%
Invesco
24
Invesco
Georgia
$12.1M 709,747 +364,924 +106%
SCM
25
Soleus Capital Management
Connecticut
$11.1M 650,000 -2,234,382 -77%
1
2 3 4 5